EGFR and skin squamous cell carcinoma: As a comparison, the median overall survival in patients with cSCC treated with traditional chemotherapy alone, including EGFR inhibitors, was 15.3 months (95% CI, 10.4-21.0) overall, with 16.2 months for locally advanced cSCC and 15.3 months for metastatic cSCC (43).